Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28912905 | 0.84 | ALDH1A1 (0.46) | POLBCA12CA1CA2CA9 | |
| SCHEMBL1232870 | 0.81 | ALDH1A1 (0.41) | POLBCA12CA1CA2CA9 | |
| SCHEMBL10990860 | 0.81 | POLB (0.39) | POLBCA12CA1CA2CA9 | |
| SCHEMBL12888849 | 0.80 | POLB (0.31) | POLB | |
| SCHEMBL1387473 | 0.79 | POLB (0.38) | POLBCA12CA1CA2CA9 | |
| SCHEMBL1387466 | 0.79 | ALDH1A1 (0.39) | POLBCA12CA1CA2CA9 | |
| SCHEMBL3108822 | 0.77 | POLB (0.37) | POLBCA12CA1CA2CA9 | |
| SCHEMBL6539776 | 0.77 | ALDH1A1 (0.54) | POLBCA12CA1CA2CA9 | |
| SCHEMBL3628031 | 0.77 | POLB (0.41) | POLBCA12CA1CA2CA9 | |
| SCHEMBL10926752 | 0.77 | POLB (0.37) | POLBCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362454-A1 | WATER BASED MAGNETIC INK CHARACTER RECOGNITION INK JET INK BASED ON DISPERSION OF FUNCTIONALIZED NANOPARTICULATE MAGNETIC FERRITE | NANUM NANOTECNOLOGIA S/A (BR) | 2017-12-21 | — | — | US | claimed |
| US-20160208120-A1 | WATER BASED MAGNETIC INK CHARACTER RECOGNITION INK JET INK BASED ON DISPERSION OF FUNCTIONALIZED NANOPARTICULATE MAGNETIC FERRITE | NANUM NANOTECNOLOGIA S/A (BR) | 2016-07-21 | — | — | US | claimed |
| US-9133070-B2 | Smokeless propellant composition containing bismuth-based compound and method of preparing the same | AGENCY FOR DEFENSE DEVELOPMENT (KR) | 2015-09-15 | — | — | US | claimed |
| US-20140338803-A1 | SMOKELESS PROPELLANT COMPOSITION CONTAINING BISMUTH-BASED COMPOUND AND METHOD OF PREPARING THE SAME | AGENCY FOR DEFENSE DEVELOPMANT (KR) | 2014-11-20 | — | — | US | claimed |
| EP-0733045-B1 | 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2001-08-16 | — | — | EP | claimed |
| US-5880130-A | TREATMENT OF CELL-PROLIFERATION DISEASES | ZENECA LIMITED (GB) | 1999-03-09 | — | — | US | claimed |
| JP-H09506363-A | — | — | 1997-06-24 | — | — | JP | claimed |
| EP-0733045-A1 | 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS | ZENECA LIMITED (GB) | 1996-09-25 | — | — | EP | claimed |
| WO-1995015952-A1 | 4,6-DIANILINO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TYROSINE KINASE INHIBITORS | ZENECA LIMITED (GB) | 1995-06-15 | — | — | WO | claimed |
| US-5179124-A | Nonsteroid antiinflammatory agents | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1993-01-12 | — | — | US | claimed |
| US-4143159-A | SKIN-CARE AGENTS CONTAINING HYDROXYALKYL CARBOXAMIDES AND PROCESS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1979-03-06 | — | — | US | claimed |
| US-20200308109-A1 | FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC (JP) | 2020-10-01 | — | — | US | disclosed |
| US-20190177271-A1 | FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF | JAPAN TOBACCO INC (JP) | 2019-06-13 | — | — | US | disclosed |
| WO-2018122495-A1 | ENERGETIC COMPOSITION COMPRISING AN AMORPHOUS BORON NANOSTRUCTURED MATERIAL | SORBONNE UNIVERSITE (FR) | 2018-07-05 | — | — | WO | disclosed |
| US-9981992-B2 | Compositions and methods for reduction of ketones, aldehydes and iminiums, and products produced thereby | THE BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY (US) | 2018-05-29 | — | — | US | disclosed |
| US-5417895-A | Bonding agents for HTPB-type solid propellants | AEROJET GENERAL CORPORATION (US) | 1995-05-23 | — | — | US | disclosed |
| US-5179124-A | Nonsteroid antiinflammatory agents | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1993-01-12 | — | — | US | disclosed |
| US-4464392-A | Process for controlling antimicrobial activity using glycolic acid derivatives | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1984-08-07 | — | — | US | disclosed |
| US-4347378-A | Antimicrobial glycolic acid derivatives | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1982-08-31 | — | — | US | disclosed |
| US-4346043-A | BIOSTATS IN COMMERCIAL PRODUCTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF AGRICULTURE (US) | 1982-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177271-A1 | FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF | FH, PCK2, PC | POLB 1201/4885CA12 2660/4885CA1 1930/4885 |
| US-20200308109-A1 | FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF | FH, PCK2, PC | POLB 1201/4885CA12 2660/4885CA1 1930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.